PA
JCI icon

PharVision Advisers’s Johnson Controls International JCI Stock Holding History

PharVision Advisers’s Portfolio JCI Stock Details JCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-3,340
Closed -$353K – 728
2025
Q2 		$353K Sell
3,340
-3,874
-54% -$357K 0.51% 42
2025
Q1 		$578K Buy
7,214
+3,678
+104% +$302K 0.8% 6
2024
Q4 		$279K Buy
+3,536
New +$284K 0.24% 182

Other funds holding JCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PharVision Advisers's JCI Position: Q3 2025 in Review

PharVision Advisers sold out of Johnson Controls International (JCI) in Q3 2025, closing a stake of 3,340 shares — an estimated $353K sold.

PharVision Advisers first reported a position in JCI in Q4 2024 and held it in 3 quarters. The position peaked at $578K in Q1 2025. 1,336 funds tracked by Wall St. Rank hold JCI as of Q3 2025.

  • PharVision Advisers reported no remaining Johnson Controls International position as of Q3 2025 after selling out during the quarter.
  • PharVision Advisers sold 3,340 Johnson Controls International shares in Q3 2025, an estimated $353K.
  • PharVision Advisers first reported a position in Johnson Controls International in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Johnson Controls International position peaked at $578K in Q1 2025.
  • 1,336 funds tracked by Wall St. Rank held Johnson Controls International as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.